Pre-Register for the May 17, 2011 Internet Symposium

[Guest guest]

Having trouble viewing this email? Click here

May 17, 2011 at 7:00 PM GMT, 3:00 PM EDT

A Live Continuing Medical Education Activity

This one-hour internet symposium will review and discuss the clinical management

of Hepatitis C co-infection in HIV-positive patients. This symposium will

feature an interview of Mark Sulkowski, MD, one of the leading experts in

Hepatitis and HIV coinfection, by Calvin Cohen, MD, MS, Research Director of CRI

New England and Clinical Instructor at Harvard Medical School.

Course Director and Moderator

Faculty:

Calvin J. Cohen, MD, MS

Research Director, CRI New England

Clinical Instructor, Harvard Medical School

Boston, Massachusetts

Mark Sulkowski, MD

Associate Professor of Medicine and

Medical Director, Viral Hepatitis Center,

s Hopkins University School of Medicine

Baltimore, land

Learning Objectives:

After completing this activity, the participant should be able to:

•

Employ clinical decisions regarding the use of new therapies becoming available

for HCV, including protease inhibitors, in HIV/HCV co-infected patients;

•

Apply key clinical research evaluating ART regimens and strategies in HIV

patients with hepatitis C co-infection;

•

Use data regarding the assessment and management of hepatitis C co-infection to

improve the overall health of HIV-positive patients.

Target Audience:

This activity is intended for physicians, physician assistants, advanced

practice nurses, and other healthcare professionals actively involved in the

treatment and management of patients with Hepatitis and HIV co-infection.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential

Areas and policies of the Accreditation Council for Continuing Medical Education

through the joint sponsorship of the Postgraduate Institute for Medicine and

ViralEd, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME

to provide continuing medical education for physicians.

Credit Designation:

The Postgraduate Institute for Medicine designates this live activity for a

maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the

credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest:

The Postgraduate Institute for Medicine requires instructors, planners, managers

and other individuals who are in a position to control the content of this

activity to disclose any real or apparent conflict of interest they may have as

related to the content of this activity. All identified conflicts of interest

are thoroughly vetted by the Postgraduate Institute for Medicine for fair

balance, scientific objectivity of studies mentioned in the materials or used as

the basis for content, and appropriateness of patient care recommendations.

Supported by an educational grant from Merck & Co., Inc.

Forward email

..

HIVandHepatitis.com | 584 Castro Street #272 | San Francisco | CA | 94114